Human papillomavirus (HPV) causes greater than 5% of cancers worldwide, including all
cervical cancers and an alarmingly increasing proportion of oropharyngeal cancers (OPCs) …

Lipid-based polymeric nanoparticles are the highly popular carrier systems for cancer drug
therapy. But presently, detailed investigations have revealed their flaws as drug delivery …

Approximately 200 human papillomaviruses (HPVs) infect human epithelial cells, of which
the alpha and beta types have been the most extensively studied. Alpha HPV types mainly …

Chapter 3 “Tumours of the hypopharynx, larynx, trachea, and parapharyngeal space” of the
World Health Organization (WHO) Blue Book 2017 “Classification of Head and Neck …

Head and neck cancer is the fifth most common cancer worldwide. It is often amenable to
curative intent therapy when localized to the head and neck region, but it carries a poor …

Undoubtedly, diagnosing and managing infections is one of the most challenging issues for
orofacial clinicians. As a result of the diversity of symptoms, complicated behavior, and …

The oral microbiome can play a role in the instigation and progression of oral diseases that
can manifest into other systemic conditions. These associations encourage the exploration …

CRISPR/Cas mediated gene-editing has opened new avenues for therapies that show great
potential for treating or curing cancers, genetic disorders, and microbial infections such as …

Head and neck carcinoma (HNC) are diseases arising from several tracts of the
aerodigestive ways. Most HNC are squamous cell carcinoma (SCCHN). Immunotherapy is a …

The last decade has brought about an unexpected rise in oropharyngeal squamous cell
carcinoma (OPSCC) primarily in white males from the ages of 40–55 years, with limited …